HLA-DQB1 and HLA-DPB1 genotypes in severe preeclampsia

Obstetrics and Gynecology

Volumn 96, Issue 3, 2000, Pages 385-389

  Honda, Keisuke ^a   Takakuwa, Koichi ^b   Hataya, Isao ^c   Yasuda, Masako ^a   Kurabayashi, Takumi ^b   Tanaka, Kenichi ^c  

^a NIIGATA UNIVERSITY   (Japan)

^b Nagaoka onto General Hospital   (Japan)

^c NAGAOKA RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN; HLA DQ ANTIGEN;

ADULT; ALLOIMMUNITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; CHROMOSOME MAPPING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HUMANS; INFANT, NEWBORN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRE-ECLAMPSIA; PREGNANCY;

EID: 0034734989     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006250-200009000-00012     Document Type: Article

References (28)

1. Gill TJ III. Immunogenetic aspects of the maternal-fetal interaction. In: Wegmann TG, Gill TJ III, eds. Immunology of reproduction. Oxford, UK: Oxford University Press, 1983:53-76.
2. Redman CWG, Sargent I. The immunology of pre-eclampsia. In: Chaouat G, ed. Immunology of pregnancy. London: CRC Press, 1993:205-30.
3. Kilpatrick DC. Influence of human leukocyte antigen and tumour necrosis factor genes on the development of pre-eclampsia. Hum Reprod Update 1999;5:94-102.
4. Schuiling GA, Koiter TR, Faas MM. Pre-eclampsia: Why preeclampsia? Hum Reprod 1997;12:2087-91.
5. Thomson G. HLA disease associations: Models for the study of complex human genetic disorders. Crit Rev Clin Lab Sei 1995;32: 183-219.
6. Redman CWG, Bodmer JG, Bodmer WF, Beilin LJ, Bonnar J. HLA antigens in severe pre-eclampsia. Lancet 1978;2:397-9.
7. Takakuwa K, Arakawa M, Tamura M, Hataya I, Higashino M, Yasuda M, et al. HLA antigens in patients with severe preeclampsia. J Perinat Med 1996;25:79-83.
8. Wilton AN, Cooper DW, Brennecke SP, Bishop SM, Marshall P. Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DR beta. Lancet 1990;336: 653-7.
9. Wilton AN, Barendse WJ, Donald JA, Marshall P, Trudinger B, Gallery ED, et al. HLA-DRB types in pre-eclampsia and eclampsia. Tissue Antigens 1991;38:137-41.
10. Takakuwa K, Honda K, Ishii K, Hataya I, Yasuda M, Tanaka K. Studies on the HLA-DRB1 genotypes in Japanese women with severe preeclampsia positive and negative for anticardiolipin antibody using a PCR-RFLP method. Hum Reprod 1999;14: 2980-6.
11. Gleicher N, El-Roeiy A. The reproductive autoimmune failure syndrome. Am J Obstet Gynecol 1988;159:223-7.
12. Yasuda M, Takakuwa K, Higashino M, Ishii S, Kazama Y, Tanaka K, et al. A typical case of reproductive autoimmune failure syndrome in which a patient experienced recurrent abortion, preeclampsia, and intrauterine growth retardation. Am J Reprod Immunol 1993;29:45-7.
13. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995;86:555-9.
14. Hataya I, Takakuwa K, Tanaka K. Human leukocyte antigen class II genotype in patients with recurrent miscarriage who are positive for anticardiolipin antibody. Fertil Steril 1998;70:919-23.
15. Christiansen OB, Ulcova-Gallova Z, Mohapeloa H, Krauz V. Studies on associations between human leukocyte antigen (HLA) class II alleles and antiphospholipid antibodies in Danish and Czech women with recurrent miscarriages. Hum Reprod 1998;13:332631.
16. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158:892-8.
17. Nomura N, Ota M, Tsuji K, Inoko H. HLA-DQB1 genotyping by a modified PCR-RFLP method combined with group-specific primers. Tissue Antigens 1991;38:53-9.
18. Ota M, Seki T, Nomura N, Sugimura K, Mizuki N, Fukushima H, et al. Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 1991 #8:60-71.
19. Margulies DH. The major histocompatibility complex. In: Paul WE, ed. Fundamental immunology. 4th ed. Philadelphia: LippincottRaven Publishers, 1999:263-85.
20. Chesley LC, Cooper DW. Genetics of hypertension in pregnancy: Possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986;93: 898-908.
21. Hayward C, Livingstone J, Holloway S, Liston WA, Brock DJ. An exclusion map for pre-eclampsia: Assuming autosomal recessive inheritance. Am J Hum Genet 1992;50:749-57.
22. Gleicher N. Antiphospholipid antibodies and reproductive failure: What they do and what they do not do; how to, and how not to treat. Hum Reprod 1997;12:13-6.
23. Takakuwa K, Asano K, Arakawa M, Yasuda M, Hasegawa I, Tanaka K. Chromosome analysis of aborted conceptuses of recurrent aborters positive for anticardiolipin antibody. Fertil Steril 1997;68:54-8.
24. Kwok WW, Nepom GT, Raymond FC. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol 1995;155:2468-76.
25. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996;106:127-33.
26. Raghupathy R. Thl-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-82.
27. Stark JM. Pre-eclampsia and cytokine induced oxidative stress. Br J Obstet Gynaecol 1993;100:105-9.
28. Marsh SGE, Bodmer JG. HLA class II nucleotide sequences. Hum Immunol 1992;35:1-17.